Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05398627 · ClinicalTrials.gov registry record · NA

Neurofeedback for Borderline Personality Disorder

A NA study of Borderline Personality Disorder, sponsored by Kymberly Young.

Active
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT05398627 is a NA study of Borderline Personality Disorder that is active but no longer recruiting, run by Kymberly Young. The registered enrollment target is 100 participants, roughly in line with the 101-participant average among 16 other Borderline Personality Disorder trials with a reported enrollment target. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05398627, a NA study of Borderline Personality Disorder, is active but no longer recruiting, sponsored by Kymberly Young.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

The goal of this study is to evaluate whether rtfMRI-nf training to increase the amygdala response to positive memories may serve as an intervention for borderline personality disorder.

Interventions

  • DEVICE Amygdala Neurofeedback

Study Locations (1)

Pennsylvania

  • University of Pittsburgh - Pittsburgh

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2022-09-02
Est. Completion 2026-04-30
Phase NA

Sponsor

Kymberly Young

4 total trials

What the Registry Record Tells You About NCT05398627

The ClinicalTrials.gov registry entry for NCT05398627 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 101-participant average among 16 other Borderline Personality Disorder trials with a reported enrollment target. The listed sponsor is Kymberly Young, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Borderline Personality Disorder appearing as the primary indexed condition, and to 1 intervention - of which Amygdala Neurofeedback is the first listed.

NCT05398627 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT05398627 about?

NCT05398627 is a clinical study titled "Neurofeedback for Borderline Personality Disorder". The goal of this study is to evaluate whether rtfMRI-nf training to increase the amygdala response to positive memories may serve as an intervention for borderline personality disorder.

What is the current status of trial NCT05398627?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2022-09-02. Estimated completion is 2026-04-30.

What conditions does trial NCT05398627 study?

This clinical trial studies the following conditions: Borderline Personality Disorder.

What interventions are being tested in trial NCT05398627?

The interventions under investigation include: Amygdala Neurofeedback (DEVICE).

Who is sponsoring clinical trial NCT05398627?

This trial is sponsored by Kymberly Young, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05398627 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Borderline Personality Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.